ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,321.41
0.25%
Dow Jones
39,872.99
0.17%
US Dollar vs MXN
16.6016
-0.12%
Brent Oil
82.295
-0.18%
Bitcoin
70,227.46
0.14%
Registration Strip Icon for default Regístrate gratis para obtener cotizaciones en tiempo real, gráficos interactivos, flujo de opciones en vivo y más.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Reino Unido
  5. LSE
  6. Celadon Pharmaceuticals Plc (CEL)

  7. Celadon Pharmaceuticals Plc (CEL) Noticias

CEL

Celadon Pharmaceuticals (CEL)

Celadon Pharmaceuticals Plc
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:LSE:CEL
FechaHoraFuenteTítuloSímboloCompañía
15/05/202408:45RNS Regulatory NewsCeladon Pharmaceuticals PLC Exercise of Share Options and Total Voting RightsLSE:CELCeladon Pharmaceuticals Plc
14/05/202413:41Alliance NewsAlliance NewsTRADING UPDATES: Headlam warns of loss; EnSilica predicts revenue riseLSE:CELCeladon Pharmaceuticals Plc
14/05/202401:00RNS Regulatory NewsCeladon Pharmaceuticals PLC Final ResultsLSE:CELCeladon Pharmaceuticals Plc
10/05/202412:57Alliance NewsAlliance NewsIN BRIEF: Celadon raises GBP2 million, extends credit facilityLSE:CELCeladon Pharmaceuticals Plc
10/05/202401:00RNS Regulatory NewsCeladon Pharmaceuticals PLC Fundraise, RCF Extension, Termination of CLN & TVRLSE:CELCeladon Pharmaceuticals Plc
08/03/202414:04Alliance NewsAlliance NewsTRADING UPDATES: Celadon hails early results of chronic pain trialLSE:CELCeladon Pharmaceuticals Plc
07/03/202401:00RNS Non-RegulatoryCeladon Pharmaceuticals PLC Early Economic Analysis of Feasibility Study DataLSE:CELCeladon Pharmaceuticals Plc
14/12/202308:18Alliance NewsAlliance NewsCeladon announces start of cannabis supply for two UK companiesLSE:CELCeladon Pharmaceuticals Plc
14/12/202301:00UK RegulatoryCeladon Pharmaceuticals PLC Product Supplied to First Two Sales ContractsLSE:CELCeladon Pharmaceuticals Plc
12/12/202311:40Alliance NewsAlliance NewsTRADING UPDATES: Celadon Pharma raises GBP2.0 million via placingLSE:CELCeladon Pharmaceuticals Plc
12/12/202308:00UK RegulatoryCeladon Pharmaceuticals PLC Fundraise, Update on Future CLN Financing & TVRLSE:CELCeladon Pharmaceuticals Plc
16/11/202305:45Alliance NewsAlliance NewsCeladon shares rise on supply contract worth up to GBP26 millionLSE:CELCeladon Pharmaceuticals Plc
16/11/202301:00UK RegulatoryCeladon Pharmaceuticals PLC New European Sales ContractLSE:CELCeladon Pharmaceuticals Plc
13/10/202309:42Alliance NewsAlliance NewsIN BRIEF: Celadon Pharmaceuticals raises GBP1.0 million through sharesLSE:CELCeladon Pharmaceuticals Plc
13/10/202301:00UK RegulatoryCeladon Pharmaceuticals PLC Fundraise, CLN Issue, Joint Broker Appointed & TVRLSE:CELCeladon Pharmaceuticals Plc
28/09/202306:14Alliance NewsAlliance NewsCeladon Pharmaceuticals interim loss narrows; optimistic for futureLSE:CELCeladon Pharmaceuticals Plc
28/09/202301:00UK RegulatoryCeladon Pharmaceuticals PLC Interim ResultsLSE:CELCeladon Pharmaceuticals Plc
18/09/202301:00UK RegulatoryCeladon Pharmaceuticals PLC Notice of Results and Investor PresentationLSE:CELCeladon Pharmaceuticals Plc
05/09/202304:48Alliance NewsAlliance NewsCeladon shares rise on second UK contract win for cannabis productLSE:CELCeladon Pharmaceuticals Plc
05/09/202301:00UK RegulatoryCeladon Pharmaceuticals PLC New Sales Contract with UK Pharmaceutical CompanyLSE:CELCeladon Pharmaceuticals Plc
01/08/202305:44Alliance NewsAlliance NewsCeladon receives approval for 5,000 patient clinical cannabis trialLSE:CELCeladon Pharmaceuticals Plc
01/08/202301:00UK RegulatoryCeladon Pharmaceuticals PLC Approval to roll-out chronic pain clinical trialLSE:CELCeladon Pharmaceuticals Plc
29/06/202311:30UK RegulatoryCeladon Pharmaceuticals PLC Result of AGMLSE:CELCeladon Pharmaceuticals Plc
05/06/202308:46UK RegulatoryCeladon Pharmaceuticals PLC Publication of Annual Report and Notice of AGMLSE:CELCeladon Pharmaceuticals Plc
05/06/202306:23Alliance NewsAlliance NewsCeladon Pharmaceuticals loss widens; confident amid three-year dealLSE:CELCeladon Pharmaceuticals Plc
05/06/202301:00UK RegulatoryCeladon Pharmaceuticals PLC Final Results for the year ended 31 December 2022LSE:CELCeladon Pharmaceuticals Plc
30/05/202305:56Alliance NewsAlliance NewsCeladon secures GBP7 million credit facility as product demand growsLSE:CELCeladon Pharmaceuticals Plc
30/05/202301:00UK RegulatoryCeladon Pharmaceuticals PLC GBP7 Million Committed Credit FacilityLSE:CELCeladon Pharmaceuticals Plc
25/05/202301:00RNS Non-RegulatoryCeladon Pharmaceuticals PLC West Midlands Mayor Visits Celadon's FacilityLSE:CELCeladon Pharmaceuticals Plc
24/05/202306:29Alliance NewsAlliance NewsCORRECT: Celadon signs commercial cannabis supply agreement in UKLSE:CELCeladon Pharmaceuticals Plc
 Showing the most relevant articles for your search:LSE:CEL

Su Consulta Reciente

AMEX
XLF
Financial Select Sector
NYSE
KO
Coca Cola
NYSE
AXP
American Express
SPI
SP500
S&P 500
NYSE
JPM
JP Morgan Chase
NASDAQ
AMZN
Amazon.com
AMEX
SPY
SPDR S&P 500
CCOM
SILVER
SILVER
NASDAQ
AAPL
Apple
NYSE
CVX
Chevron
NYSE
VZ
Verizon Communications
USOTC
BNPQY
BNP Paribas (QX)
COIN
SOLUSD
Solana
COIN
BTCUSD
Bitcoin
FX
EURUSD
Euro vs US Dollar
USOTC
BASFY
BASF (QX)
Delayed Upgrade Clock
ADVFN Logo

México
Empresa
Negocios
Popular
Obtener la aplicación

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados